A substance being studied in the treatment of leukemias and lymphomas. It is also being studied in the treatment of other types of cancer. TPA affects many cell actions and may cause tumor cells to die. It is a type of phorbol ester. Also called 12-O-tetradecanoylphorbol-13-acetate and tetradecanoylphorbol acetate. Found on http://www.cancer.gov/dictionary?expand=T
An enzyme made in the body that helps dissolve blood clots. A form of this enzyme is made in the laboratory to treat heart attacks, strokes, and clots in the lungs. It is also being studied in the treatment of cancer. tPA is a type of systemic thrombolytic agent. Also called tissue plasminogen activator. Found on http://www.cancer.gov/dictionary?expand=T
Tissue plasminogen activator or TPA is thrombolytic agent used to dissolve blood clots. TPA is introduced into a vein (intravenous) or directly into a blocked artery. Because TPA is produced using recombinant DNA technology, it tends to be more expensive than urokinase or streptokinase. ... (27 Sep 1997) ... Found on http://www.encyclo.co.uk/local/20973
t-PA t-plasminogen activator. total parenteral alimentation (see parenteral nutrition); t-plasminogen activator. Found on http://www.encyclo.co.uk/local/21001
(1) See tissue plasminogen activator. (2) A phorbol ester tumour promoter, 12-O-tetradecanoyl-phorbol-13-acetate also known as PMA, phorbol myristyl acetate.
Found on http://www.encyclo.co.uk/visitor-contributions.php